Joseph Zimmermann
Director/Board Member at IBEX TECHNOLOGIES
Profile
Joseph Zimmermann is the founder of Biodextris, Inc. which was founded in 2015, where he holds the title of President & Chief Executive Officer.
He is currently the President & Chief Executive Officer at Inspirevax, Inc. and an Independent Director at IBEX Technologies, Inc. where he started in 2017.
Dr. Zimmermann's former positions include Director-Process Development & Project at ID Biomedical Corp.
and Director-New Product Development at GlaxoSmithKline, Inc. where he worked from 2002 to 2015.
Dr. Zimmermann's education includes an undergraduate degree from The Trustees of Columbia University in The City of New York, a graduate degree from the University of Cambridge, and a doctorate from the Massachusetts Institute of Technology.
Joseph Zimmermann active positions
| Companies | Position | Start |
|---|---|---|
| IBEX TECHNOLOGIES | Director/Board Member | 10/10/2017 |
Biodextris, Inc.
 Biodextris, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Clean Cells SAS, Biodextris, Inc. is a contract research organization based in Laval, Canada. The Canadian company provides analytical, process development, and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris' expertise, facilities, and quality systems support clients in navigating a path from R&D to early-phase clinical trials. The company was founded in 2015 by Joseph Zimmermann, who has been the CEO since then. On May 05, 2021, Biodextris was acquired by Clean Cells SAS. | Chief Executive Officer | 31/08/2015 |
| Inspirevax, Inc. | Chief Executive Officer | - |
Former positions of Joseph Zimmermann
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 31/08/2015 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Training of Joseph Zimmermann
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| University of Cambridge | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Biodextris, Inc.
Biodextris, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Clean Cells SAS, Biodextris, Inc. is a contract research organization based in Laval, Canada. The Canadian company provides analytical, process development, and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris' expertise, facilities, and quality systems support clients in navigating a path from R&D to early-phase clinical trials. The company was founded in 2015 by Joseph Zimmermann, who has been the CEO since then. On May 05, 2021, Biodextris was acquired by Clean Cells SAS. | Commercial Services |
| Inspirevax, Inc. |
- Stock Market
- Insiders
- Joseph Zimmermann
